戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 section remains the mainstay of treatment of hilar cholangiocarcinoma.
2 herapy followed by liver transplantation for hilar cholangiocarcinoma.
3 ates after aggressive surgical resections of hilar cholangiocarcinoma.
4 t determinant of survival after resection of hilar cholangiocarcinoma.
5 between patients with gallbladder cancer and hilar cholangiocarcinoma.
6 lecystectomy), but only 25% in patients with hilar cholangiocarcinoma.
7 ve and only potentially curative therapy for hilar cholangiocarcinoma.
8 umor extent, the proposed staging system for hilar cholangiocarcinoma accurately predicts resectabili
9 rround the issues of extent of resection for hilar cholangiocarcinoma and whether the histopathology
10 ts receiving endoscopic biliary drainage for hilar cholangiocarcinoma between September 1995 and Dece
11        The yield of laparoscopy is lower for hilar cholangiocarcinoma but can be improved by targetin
12        Sixty-five patients with unresectable hilar cholangiocarcinoma (CCA) have undergone orthotopic
13                             In patients with hilar cholangiocarcinoma, concomitant hepatic resection
14 formed a review of the English literature on hilar cholangiocarcinoma from 1990 to 2007.
15      Between 1997 and 2004, 80 patients with hilar cholangiocarcinoma having surgery were reviewed.
16 de (LN) assessment after liver resection for hilar cholangiocarcinoma (HC) is still controversial, an
17                 A total of 257 patients (144 hilar cholangiocarcinoma [HCCA] and 113 distal bile duct
18 ntrahepatic cholangiocarcinoma (IH; n = 23), hilar cholangiocarcinoma (Hilar; n = 54), gallbladder (G
19 ic resection in hepatocellular carcinoma and hilar cholangiocarcinoma improves survival.
20 urvival in patients with surgically resected hilar cholangiocarcinoma in a single institution over th
21                                              Hilar cholangiocarcinoma is a rare tumor with a poor pro
22                                              Hilar cholangiocarcinoma is an uncommon tumor with a poo
23               Endoscopic biliary drainage of hilar cholangiocarcinoma is controversial with respect t
24 of intrahepatic cholangiocarcinoma (ICC) and hilar cholangiocarcinoma (Klatskin tumors) is limited to
25                             In patients with hilar cholangiocarcinoma, long-term survival depends cri
26 y resectable gallbladder cancer (n = 44) and hilar cholangiocarcinoma (n = 56) were prospectively eva
27         SEMS insertion for the palliation of hilar cholangiocarcinoma offers higher technical and cli
28 s the majority of patients with unresectable hilar cholangiocarcinoma or gallbladder carcinoma, there
29 r the study period was compared with that of hilar cholangiocarcinoma patients (HCCA) seen during the
30 ant therapy followed by liver transplant for hilar cholangiocarcinoma, placed in context with the mos
31         From 1985 to 2006, all patients with hilar cholangiocarcinoma referred to a tertiary surgical
32                                              Hilar cholangiocarcinoma remains a difficult challenge f
33                         Ninety patients with hilar cholangiocarcinomas seen between March 1, 1991, an
34 y gallbladder cancer and patients with T2/T3 hilar cholangiocarcinoma should undergo staging laparosc
35  locally advanced but potentially resectable hilar cholangiocarcinoma, the yield of laparoscopy was g
36 ompares outcome after resection of papillary hilar cholangiocarcinoma to that of the more common nodu
37 uated endoscopic palliation in patients with hilar cholangiocarcinoma using self-expandable metallic
38 urvival was most favorable when resection of hilar cholangiocarcinoma was accomplished with margin-ne
39 ogic, and survival data on all patients with hilar cholangiocarcinoma were analyzed.
40                For patients with early stage hilar cholangiocarcinoma which is unresectable or arisin
41 and bile-duct resection can be performed for hilar cholangiocarcinoma with acceptable mortality, thou

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。